Arena Pharmaceuticals, Inc.
NASDAQ: ARNA
$99.99
+$0.00 (+0.0%)
Closing Price on March 15, 2022
ARNA Articles
These are this Friday morning’s top day trader and active trader alert stocks with moves on unusual volume. We have also provided more details on price and volume analysis with links through to...
Published:
Last Updated:
Here are Wednesday’s top day trader and active trader alerts with more detailed trading volume and price analysis in the links over at VSInvestor.com: General Electric Co. (NYSE:GE) is challenging...
Published:
Last Updated:
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a recent dig down for...
Published:
Last Updated:
It seems that there is another endless line of biotech and emerging pharmaceutical companies which have raised cash or have filed to raise cash. MannKind Corporation (NASDAQ: MNKD), Idenix...
Published:
Last Updated:
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Published:
These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours volume activity with links to more detailed price and volume analysis on each...
Published:
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is getting shelled this morning. The company released “positive study data” this morning on trials for its obesity treatment Lorcaserin. But the...
Published:
Last Updated:
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) has filed to sell up to 25 million shares of common stock in a public secondary offering. Underwriters were not listed. Arena is a clinical-stage...
Published:
Last Updated:
Barr Pharmaceuticals (BRL) Says business pace is falling off. Down to $37.40 from 52-week high of $58.38. Tesoro Corporation (TSO) Broker downgrade. Dips to $22.92 from 52-week high of $65.98....
Published:
These are not the only impact analyst calls this morning, but these are the top calls that a673b.bigscoots-temp.com is focusing on: ABB Ltd. (NYSE: ABB) downgraded to SELL from Hold at Citigroup. Amylin Pharma...
Published:
Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs haven’t been immune. You can even see that the Biotech HOLDRs (BBH) at $160+ are only about...
Published:
Last Updated:
Business Week noted Arena Pharmaceuticals Inc. (NASDAQ:ARNA) as one of its three "Inside Wall Street" weekly stock picks this morning, and frankly it was the only pick with any sizzle to it. Arena...
Published:
Last Updated: